Biossil is an applied AI drug discovery platform, focused on developing targeted therapies for biologically defined patient sub-populations. Biossil’s advanced multimodal AI platform combines and synthesizes over a trillion data points to uncover the molecular basis of disease variability and to identify therapies that are precisely targeted to the right patients.
Founders: Anthony Mouchantaf and Alex Mosa.
AI copilot for clinical research
Applied AI drug discovery platform
AI database management platform
Software for the live event industry
Digital payments platform for fleets
Waste logistics software
Unified TV and Film production workflow platform
AI for residential real estate agents
AI software for retail pharmacies
PropTech for residential real estate
Advanced AI for investment research
AI for medical claim reviews
B2B commerce suite for textiles
AI platform for regulatory processes
AI-Powered planning software